CAL
SRNE

Capital Analysts LLC’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Capital Analysts LLC’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$4K – 1114
2021
Q1 		$4K Buy
+500
New +$4K ﹤0.01% 906
2020
Q4 		– Sell
-1,500
Closed -$17K – 826
2020
Q3 		$17K Buy
+1,500
New +$17K ﹤0.01% 528